You are here: Home  > Netscape WebMail 
Netscape WebMail By USA.Net
 
 Read Mail
Inbox , Message 13 of 100 (NEW)    
 

 
Date: Fri, 30 Apr 99 01:59AM PDT
From:
"Bill Asenjo, PhD candidate, CRC" <[email protected]>    Add To Address Book  Add To Junk Mail Blocker List
To: [email protected]
Subject: Chinese Herb blocks cancer cell division
  

More Details
  

  
SOURCE: Nature Cell Biology 1999;1:60-67.

Chinese herb blocks division of
cancer cells
(Last updated 6:18 PM ET April 28)


NEW YORK, Apr 28 (Reuters Health) -- For centuries, the
Chinese herbal medicine called Danggui Longhui Wan has
been used in the treatment of leukemia. In an article
published this week in Nature Cell Biology, European
researchers report that they have discovered that the active
ingredient in the herbal remedy works by blocking the
proliferation of cancer cells.

The team, led by Ralph Hoessel of the University of
Kaiserslautern in Germany, note that Danggui Longhui Wan
includes 11 different herbal medicines. More than 30 years
ago, researchers at the Chinese Academy of Medical
Sciences identified the active ingredient in this complex
mixture as Qing Dai, a dark blue powder prepared from
various plants and containing a large amount of the blue dye
indigo.

The leukemia-fighting ingredient was found to be indirubin, a
red-colored relative of the indigo blue dye.

Hoessel's team believes that indirubin stops the uncontrolled
growth of tumor cells by inactivating enzymes called
cyclin-dependent kinases that govern cell division.

When indirubin binds to these enzymes, it blocks their
activity and halts cell division, thus stopping the proliferation
of cancer cells.

The investigators note that indirubin has been approved for
clinical trials in patients with chronic myelocytic and chronic
granulocytic leukemia. One study found that "26% of the 314
chronic myelocytic leukemia patients showed complete
remission and 33% showed partial remission in response to
indirubin treatment. Toxicity was low and side effects were
limited to mild abdominal pain, diarrhea, nausea and
vomiting," they report.

Hoessel and colleagues plan to continue studying how
indirubin works. They conclude that this information may help
to optimize the use of the agent in fighting cancer, and may
suggest new avenues for cancer research.


~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
This message distributed by the BRAINTMR list. The original author is
responsible for its content. Use of this forum is for discussion purposes
only. Consult with your personal healthcare provider on medical matters.
For Questions or signoff assistance: mailto:[email protected]


 

Help   |   Site Map   |   Company Information   |   Advertise With Us
Autos   |   Business   |   Computers & Internet   |   Education   |   Entertainment   |   Games   |   Health   |   Kids & Family   |   Lifestyles   |   Local   |   Netscape   |   News   |   Personal Finance   |   Real Estate   |   Shopping   |   Sports   |   Travel
Copyright © 1999 USA.NET, Inc.